What is BPC-157? A plain-English explainer
A lab-made copy of a short fragment of a protein found in gastric juice.
BPC-157 is a synthetic peptide — a chain of 15 amino acids modelled on a short fragment of a larger protein that occurs in gastric (stomach) juice. “BPC” stands for Body Protection Compound; the number is just a lab identifier. It is sold and studied as a research chemical, not an approved medicine.
That one paragraph is the whole definition. The rest of this page unpacks it at two levels — plain English, then a little deeper — and shows how the reconstitution math works, because BPC-157 ships as a dried powder that has to be mixed and measured before anything else.
BPC-157 in plain English
BPC-157 is 15 amino acids long, which puts it firmly in peptide territory — a short chain, where the protein it’s modeled on runs far longer.
The sequence it’s based on was identified in a protein found in the stomach. Researchers synthesised a stable 15-amino-acid fragment of it in the lab and gave it the code BPC-157. So when you see the name, read it as: a specific, lab-made short peptide, nothing more mysterious than that.
It usually arrives as a small glass vial of white powder. The powder is the peptide with the water removed (freeze-dried, or “lyophilised”) so it stays stable in storage. On its own the powder can’t be measured into a syringe — there’s no volume to draw. That’s why the next step, reconstitution, exists.
The science, a little deeper
A few specifics that the plain-English version glosses over:
- It’s a defined sequence, not a mixture. BPC-157 is a single, known 15-amino-acid sequence. That’s what makes it a peptide in the chemical sense rather than an extract.
- It’s supplied lyophilised. Removing the water gives the powder a long shelf life; adding a measured liquid back (reconstitution) is what turns it into an injectable solution with a known strength.
- “Research chemical” is a regulatory status, not a marketing word. BPC-157 has not been approved as a drug. Most of what’s published about it is preclinical — laboratory and animal studies — and this page makes no claim about what it does in people.
If you want the classification in one line: BPC-157 is a synthetic research peptide, 15 amino acids, supplied as a freeze-dried powder for reconstitution.
How reconstitution works for BPC-157
Reconstitution is just dissolving the powder in a known volume of liquid so you have a concentration — milligrams of peptide per millilitre of solution. Once the concentration is fixed, the volume you draw for any target dose is simple arithmetic:
- Concentration = vial amount (mg) ÷ diluent volume (mL)
- Draw volume = target dose ÷ concentration
- Syringe units = draw volume (mL) × the units-per-mL of your syringe
The numbers all come from your own vial label and your prescription — the peptide amount printed on the vial, the volume of bacteriostatic water you add, and the dose you were told to use. The separate Amidra web calculator runs exactly those three steps and shows the formula at each one, so you can check it by hand. It never fills in a dose for you.
What Amidra does — and doesn’t — do here
Amidra is a tracking and education tool. It converts the values you enter and helps you keep a protocol organised; it does not recommend a dose, a compound, or a schedule, and it takes no position on whether anyone should use BPC-157. Those decisions belong with a qualified healthcare professional. The information above is definitional — what the compound is — not medical advice.